184 related articles for article (PubMed ID: 14060)
1. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
[TBL] [Abstract][Full Text] [Related]
2. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
Ohmura I; Inagaki C; Araki H; Tanaka C
Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
[TBL] [Abstract][Full Text] [Related]
4. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylase.
Inagaki C; Tanaka C
Biochem Pharmacol; 1978 Apr; 27(7):1081-6. PubMed ID: 26357
[No Abstract] [Full Text] [Related]
6. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxphenylserine in the rat heart.
Araki H; Fujiwara H; Tanaka C
J Pharm Pharmacol; 1981 Dec; 33(12):778-82. PubMed ID: 6121849
[TBL] [Abstract][Full Text] [Related]
9. Optimal production of L-threo-2,3-dihydroxyphenylserine (L-threo-DOPS) on a large scale by diastereoselectivity-enhanced variant of L-threonine aldolase expressed in Escherichia coli.
Gwon HJ; Yoshioka H; Song NE; Kim JH; Song YR; Jeong DY; Baik SH
Prep Biochem Biotechnol; 2012; 42(2):143-54. PubMed ID: 22394063
[TBL] [Abstract][Full Text] [Related]
10. L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug.
Goldstein DS
Cardiovasc Drug Rev; 2006; 24(3-4):189-203. PubMed ID: 17214596
[TBL] [Abstract][Full Text] [Related]
11. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
[TBL] [Abstract][Full Text] [Related]
12. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
Maruyama W; Nakahara D; Naoi M
J Neural Transm Park Dis Dement Sect; 1994; 7(1):21-33. PubMed ID: 8579767
[TBL] [Abstract][Full Text] [Related]
13. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
Satoh S; Oyabe A; Tanno M; Suzuki-Kusaba M
Arzneimittelforschung; 1989 Sep; 39(9):1123-9. PubMed ID: 2511849
[TBL] [Abstract][Full Text] [Related]
14. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
Ogawa N; Yamamoto M; Takayama H
J Med; 1985; 16(5-6):525-34. PubMed ID: 3938472
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
[TBL] [Abstract][Full Text] [Related]
16. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
[TBL] [Abstract][Full Text] [Related]
17. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
Maruyama W; Naoi M; Narabayashi H
J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
[TBL] [Abstract][Full Text] [Related]
18. [Formation of norapinephrine in the rat brain after administration of ((+)-erythro-3,4-dihydroxyphenylserine(author's transl)].
Constantinidis J; Geissbuhler F; Gaillard JM; Aubert C; Hovaguimian TH; Tissot R
Psychopharmacologia; 1975; 41(3):201-9. PubMed ID: 1153609
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
Sato E; Irie T; Katsube J
Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
[TBL] [Abstract][Full Text] [Related]
20. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
